The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus. The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Ophthalmology

Volumn 117, Issue 1, 2010, Pages 63-70

  Klein, Ronald ^a   Lee, Kristine E ^a   Gangnon, Ronald E ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; CATARACT; DIABETIC RETINOPATHY; DIPLOPIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED STATES; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INSULIN; MALE; RISK FACTORS; TIME FACTORS; VISION DISORDERS; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS; WISCONSIN;

EID: 72749093057     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.06.051     Document Type: Article

References (40)

1. Buch H., Vinding T., and Nielsen N.V. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology 108 (2001) 2347-2357
2. Congdon N.G., Friedman D.S., and Lietman T. Important causes of visual impairment in the world today. JAMA 290 (2003) 2057-2060
3. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
4. Zhang X., Gregg E.W., Cheng Y.J., et al. Diabetes mellitus and visual impairment: National Health and Nutrition Examination Survey, 1999-2004. Arch Ophthalmol 126 (2008) 1421-1427
5. Moss S.E., Klein R., and Klein B.E. The incidence of vision loss in a diabetic population. Ophthalmology 95 (1988) 1340-1348
6. Agardh E., Agardh C.D., and Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 10 (1993) 555-559
7. Moss S.E., Klein R., and Klein B.E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101 (1994) 1061-1070
8. Henricsson M., Tyrberg M., Heijl A., and Janzon L. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. Acta Ophthalmol Scand 74 (1996) 533-538
9. Trautner C., Icks A., Haastert B., et al. Incidence of blindness in relation to diabetes: a population-based study. Diabetes Care 20 (1997) 1147-1153
10. Backlund L.B., Algvere P.V., and Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 14 (1997) 732-740
11. Moss S.E., Klein R., and Klein B.E. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105 (1998) 998-1003
12. Miki E., Lu M., Lee E.T., et al., WHO Multinational Study Group. The incidence of visual impairment and its determinants in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 suppl (2001) S31-S36
13. Voutilainen-Kaunisto R.M., Terasvirta M.E., Uusitupa M.I., and Niskanen L.K. Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects: 10-year follow-up from the diagnosis. J Diabetes Complications 15 (2001) 24-33
14. Kumar N., Goyder E., and McKibbin M. The incidence of visual impairment due to diabetic retinopathy in Leeds. Eye 20 (2006) 455-459
15. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (1984) 520-526
16. Klein R., Klein B.E., and Moss S.E. Visual impairment in diabetes. Ophthalmology 91 (1984) 1-9
17. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107 (1989) 237-243
18. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112 (1994) 1217-1228
19. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105 (1998) 1801-1815
20. Klein B.E., Klein R., McBride P.E., et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 164 (2004) 1917-1924
21. Klein R., Knudtson M.D., Lee K.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115 (2008) 1859-1868
22. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102 (1984) 527-532
23. Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program. Prev Med 5 (1976) 207-215
24. Early Treatment Diabetic Retinopathy Study (ETDRS). Manual of Operations (1985), National Eye Inst, Bethesda, MD 101-119 NTIS PB85-223006
25. Diabetic Retinopathy Study Research Group. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21 (1981) 210-226
26. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: IV. Diabetic macular edema. Ophthalmology 91 (1984) 1464-1474
27. Moss S.E., Klein R., Klein B.E., et al. Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 41 (1988) 645-649
28. Klein R., and Moss S. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 155 (1995) 745-754
29. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
30. Parmar M.K., and Machin D. Survival Analysis: A Practical Approach (1995), Wiley, New York 160-177
31. Dwyer M.S., Melton III L.J., Ballard D.J., et al. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 8 (1985) 316-322
32. Lovestam-Adrian M., Agardh C.D., Torffvit O., and Agardh E. Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in type 1 diabetic patients under routine care. J Diabetes Complications 15 (2001) 287-294
33. McFarland R.A. The effects of exposure to small quantities of carbon monoxide on vision. Ann N Y Acad Sci 174 (1970) 301-312
34. Klein B.E., Klein R., Linton K.L., and Franke T. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prev Med 9 (1993) 27-30
35. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317 (1998) 703-713
36. UK Prospective Diabetes Study (UKPDS) Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 122 (2004) 1631-1640
37. Schrier R.W., Estacio R.O., Esler A., and Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 61 (2002) 1086-1097
38. Chaturvedi N., Sjolie A.K., Stephenson J.M., et al., EUCLID Study Group. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 351 (1998) 28-31
39. Sjolie A.K., Klein R., Porta M., et al., DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 372 (2008) 1385-1393
40. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117 (1999) 1487-1495